A new vision for passenger rail is on track in southeastern Wisconsin. The MARK Rail project — short for Milwaukee Area-Racine-Kenosha Passenger Rail — has officially launched, replacing the long-disc ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback